+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Throat Cancer Drug"

From
Throat Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Throat Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Throat cancer is a type of cancer that affects the throat, voice box, and other parts of the throat. It is a form of head and neck cancer and is typically treated with surgery, radiation, and chemotherapy. Oncology drugs are used to treat cancer, including throat cancer. These drugs can be used to reduce the size of tumors, reduce the spread of cancer, and reduce the side effects of cancer treatments. Oncology drugs for throat cancer can be divided into two categories: targeted therapies and immunotherapies. Targeted therapies are designed to target specific cancer cells, while immunotherapies are designed to boost the body's own immune system to fight cancer. These drugs can be used alone or in combination with other treatments. The throat cancer drug market is a rapidly growing market, with new drugs being developed to treat this type of cancer. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more